Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
clinical trials
fda
larotrectinib
loxo oncology
roche
american society of clinical oncology (asco)
amy heimberer
anti-inflammatory drugs
arcturus therapeutics
arena pharmaceuticals
avrobio
barrow neurological institute
What
cancer
4
×
drug
4
×
medicine
fda
ahead
alzheimer's
ambien
american
annual
approved
asco
attendees
attention
bad
biotech
brain
camp’s
case
cash
chicago
city
clinical
combinations
community’s
days
deeper
disease
dna
doses
eisai
expanding
failed
fight
fingerprint
flags
focus
fortune
genetic
goes
going
Language
unset
Current search:
drug
×
cancer
×
" detroit top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More